Sponsy is disrupting the sponsorship industry. It is a one-stop online solution for sponsors and sponsees to conduct sponsorship deals. By tokenizing sponsorship assets and decentralizing decision-making, we do not only reduce costs, but also provide sponsees with a wider choice of sponsorship opportunities and make sponsorships available to every business.

Expected to kick off in 2018, the Fan-Controlled Football League (FCFL) reimagines American football – and the experience of being a die-hard fan – for the digital age. The FCFL will seek to deliver a compelling football product that captivates a broader digital audience. It will feature fast-paced, high-scoring action that embraces the spread-football evolution of the NCAA football and NFL games while enabling a diverse set of styles and strategies on both offense and defense ─ all controlled by the fans. Player personnel and real-time play calling decisions are all made by fans via the league’s blockchain platform, making fans the coach and general manager for their team. Fans will no longer be just viewers; rather, they will be active contributors to the games they are watching. This is a transformational shift in the way sports fans engage and interact: no more sitting back and passively watching as a team’s roster takes shape or a game unfolds. They will be essential to the league’s product both on the field and off. This is the democratization of sports, and it’s about to be realized through the most innovative sports league ever created, thanks to decentralized blockchain technology.

Feniks.Finance is a new financial blockchain based system, created on a fundamentally new concept, capable of scaling its speed as needed and adding new functionality. Feniks.Finance can be used as an international banking system for information transfer and payment execution. The first version of Feniks.Finance will be able to handle payments and storage of users' funds. Namely, the banking transactions labeled in the SWIFT system with MT103 as payment sent and MT202 as a receipt and crediting of the payment to the account. The next step in the development of the system will be a 700 group of SWIFT operations, namely documentary transactions better known as guarantees and letters of credit. The introduction of the 500 group, that is, the operation with securities, suggests that an exchange will appear in our network.

The StealthCrypto® utility token will be the native cryptocurrency of the StealthCrypto® system. Funds collected through the token sale will be used to develop as well as activate and purchase StealthCrypto Cloud® products and products in the StealthCrypto® ecosystem. The values of StealthCrypto® tokens are fully dependent upon the developments of Stealth Grid™ and market demand.

ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.